These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 21624563)

  • 21. Is in vivo amyloid distribution asymmetric in primary progressive aphasia?
    Martersteck A; Murphy C; Rademaker A; Wieneke C; Weintraub S; Chen K; Mesulam MM; Rogalski E;
    Ann Neurol; 2016 Mar; 79(3):496-501. PubMed ID: 26600088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-invasive Standardised Uptake Value for Verification of the Use of Previously Validated Reference Region for [
    de Vries BM; Timmers T; Wolters EE; Ossenkoppele R; Verfaillie SCJ; Schuit RC; Scheltens P; van der Flier WM; Windhorst AD; van Berckel BNM; Boellaard R; Golla SSV
    Mol Imaging Biol; 2021 Aug; 23(4):550-559. PubMed ID: 33443720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18).
    Wong DF; Rosenberg PB; Zhou Y; Kumar A; Raymont V; Ravert HT; Dannals RF; Nandi A; Brasić JR; Ye W; Hilton J; Lyketsos C; Kung HF; Joshi AD; Skovronsky DM; Pontecorvo MJ
    J Nucl Med; 2010 Jun; 51(6):913-20. PubMed ID: 20501908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Florbetapir (18F) for brain amyloid positron emission tomography: highlights on the European marketing approval.
    Cortes-Blanco A; Prieto-Yerro C; Martinez-Lazaro R; Zamora J; Jiménez-Huete A; Haberkamp M; Pohly J; Enzmann H; Zinserling J; Strassmann V; Broich K
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S395-9. PubMed ID: 24418060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation dosimetry and pharmacokinetics of florbetapir (
    Nakano M; Nakamura T; Takita Y; Uenaka K; Ando T; Senda M; Joshi AD; Lu M; Breault C; Pontecorvo MJ
    Ann Nucl Med; 2019 Aug; 33(8):639-645. PubMed ID: 31140155
    [No Abstract]   [Full Text] [Related]  

  • 26. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.
    Choi SR; Golding G; Zhuang Z; Zhang W; Lim N; Hefti F; Benedum TE; Kilbourn MR; Skovronsky D; Kung HF
    J Nucl Med; 2009 Nov; 50(11):1887-94. PubMed ID: 19837759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid PET Imaging: Standardization and Integration with Other Alzheimer's Disease Biomarkers.
    Morbelli S; Bauckneht M
    Methods Mol Biol; 2018; 1750():203-212. PubMed ID: 29512074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages.
    Raposo N; Planton M; Péran P; Payoux P; Bonneville F; Lyoubi A; Albucher JF; Acket B; Salabert AS; Olivot JM; Hitzel A; Chollet F; Pariente J
    Neurology; 2017 Aug; 89(7):697-704. PubMed ID: 28724587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of [
    Golla SS; Verfaillie SC; Boellaard R; Adriaanse SM; Zwan MD; Schuit RC; Timmers T; Groot C; Schober P; Scheltens P; van der Flier WM; Windhorst AD; van Berckel BN; Lammertsma AA
    J Cereb Blood Flow Metab; 2019 Nov; 39(11):2172-2180. PubMed ID: 29897009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Theoretical impact of Florbetapir (18F) amyloid imaging on diagnosis of alzheimer dementia and detection of preclinical cortical amyloid.
    Beach TG; Schneider JA; Sue LI; Serrano G; Dugger BN; Monsell SE; Kukull W
    J Neuropathol Exp Neurol; 2014 Oct; 73(10):948-53. PubMed ID: 25192053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.
    Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal validity of PET-based staging of regional amyloid deposition.
    Jelistratova I; Teipel SJ; Grothe MJ
    Hum Brain Mapp; 2020 Oct; 41(15):4219-4231. PubMed ID: 32648624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-FDG and 18F-florbetapir PET in clinical practice: regional analysis in mild cognitive impairment and Alzheimer disease.
    Bailly M; Ribeiro MJ; Vercouillie J; Hommet C; Gissot V; Camus V; Guilloteau D
    Clin Nucl Med; 2015 Feb; 40(2):e111-6. PubMed ID: 25549345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease.
    Kobylecki C; Langheinrich T; Hinz R; Vardy ER; Brown G; Martino ME; Haense C; Richardson AM; Gerhard A; Anton-Rodriguez JM; Snowden JS; Neary D; Pontecorvo MJ; Herholz K
    J Nucl Med; 2015 Mar; 56(3):386-91. PubMed ID: 25655625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios.
    Landau SM; Fero A; Baker SL; Koeppe R; Mintun M; Chen K; Reiman EM; Jagust WJ
    J Nucl Med; 2015 Apr; 56(4):567-74. PubMed ID: 25745095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
    Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
    Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of [¹⁸F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease.
    Snellman A; Rokka J; Lopez-Picon FR; Eskola O; Wilson I; Farrar G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1784-95. PubMed ID: 22801729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of visually equivocal amyloid PET findings from the Alzheimer's Disease Neuroimaging Initiative cohort.
    Oh M; Seo M; Oh SY; Kim H; Choi BW; Oh JS; Kim JS;
    Neuroreport; 2018 May; 29(7):553-558. PubMed ID: 29438267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET.
    Rominger A; Brendel M; Burgold S; Keppler K; Baumann K; Xiong G; Mille E; Gildehaus FJ; Carlsen J; Schlichtiger J; Niedermoser S; Wängler B; Cumming P; Steiner H; Herms J; Haass C; Bartenstein P
    J Nucl Med; 2013 Jul; 54(7):1127-34. PubMed ID: 23729696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue.
    Ni R; Gillberg PG; Bergfors A; Marutle A; Nordberg A
    Brain; 2013 Jul; 136(Pt 7):2217-27. PubMed ID: 23757761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.